Specializing in foot and ankle orthopedic solutions, this company designs and markets surgical implants and instruments for lower extremity procedures. Investors monitor its growth potential in the $3B+ foot and ankle device market, where it competes with larger medtech firms.
2 members of Congress have disclosed 5 trades in Paragon 28, Inc. (FNA), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 2 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-03-04 | Gilbert Cisneros | sell | $1K – $15K |
| 2025-02-27 | Josh Gottheimer | sell | $1K – $15K |
| 2025-01-29 | Gilbert Cisneros | buy | $1K – $15K |
| 2024-07-19 | Josh Gottheimer | buy | $1K – $15K |
| 2024-04-05 | Josh Gottheimer | buy | $1K – $15K |